Stay updated on Spartalizumab Combinations in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Spartalizumab Combinations in Melanoma Clinical Trial page.

Latest updates to the Spartalizumab Combinations in Melanoma Clinical Trial page
- Check3 days agoChange DetectedThe page’s UI revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site software update rather than a change to the underlying study record.SummaryDifference0.1%

- Check11 days agoChange DetectedAdded revision v3.5.2 to the record history and removed revision v3.5.0.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check39 days agoChange DetectedThe record history adds Revision: v3.5.0 and removes Revision: v3.4.3.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision entry v3.4.3 was added and v3.4.2 was removed in the record history.SummaryDifference0.1%

- Check75 days agoChange DetectedA new revision entry (v3.4.2) was added to the history. The funding-status notice associated with v3.4.1 was removed.SummaryDifference0.4%

- Check82 days agoChange DetectedNotice about government funding lapse is now displayed and Revision: v3.4.1 was added (with Revision: v3.4.0 removed). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Spartalizumab Combinations in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Spartalizumab Combinations in Melanoma Clinical Trial page.